Targeting beta-arrestins in myeloid malignancies
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Department of Defense
Start Date
September 30, 2020
End Date
September 29, 2024
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Department of Defense
Start Date
September 30, 2020
End Date
September 29, 2024